Health Economic Evaluation of Lung Cancer Screening Using a Diagnostic Blood Test: The Early Detection of Cancer of the Lung Scotland (ECLS).
Jose Antonio Robles-ZuritaNicola McMeekinFrank M SullivanFrances S MairAndrew BriggsPublished in: Current oncology (Toronto, Ont.) (2024)
The ECLS intervention is the most cost-effective screening alternative, with the highest probability of being cost-effective, when compared to no screening or LDCT screening. This result may change with modifications of the parameters, suggesting that the three alternatives considered in the main analysis are potentially cost-effective.